Related Experiment Video
Updated: Aug 7, 2025

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
The Complement System in Kidney Transplantation
Donata Santarsiero1, Sistiana Aiello1
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 24126 Bergamo, Italy.
Abstract:
Kidney transplantation is the therapy of choice for patients who suffer from end-stage renal diseases. Despite improvements in surgical techniques and immunosuppressive treatments, long-term graft survival remains a challenge. A large body of evidence documented that the complement cascade, a part of the innate immune system, plays a crucial role in the deleterious inflammatory reactions that occur during the transplantation process, such as brain or cardiac death of the donor and ischaemia/reperfusion injury. In addition, the complement system also modulates the responses of T cells and B cells to alloantigens, thus playing a crucial role in cellular as well as humoral responses to the allograft, which lead to damage to the transplanted kidney. Since several drugs that are capable of inhibiting complement activation at various stages of the complement cascade are emerging and being developed, we will discuss how these novel therapies could have potential applications in ameliorating outcomes in kidney transplantations by preventing the deleterious effects of ischaemia/reperfusion injury, modulating the adaptive immune response, and treating antibody-mediated rejection.
Insights
The complement system significantly impacts kidney transplant outcomes. Novel therapies targeting this system show promise for improving graft survival by reducing injury and rejection.
Area of Science:
- Immunology
- Transplantation Science
- Nephrology
Background:
- Kidney transplantation is the preferred treatment for end-stage renal disease.
- Long-term graft survival remains a challenge despite advancements in surgical and immunosuppressive strategies.
- The complement cascade, a key innate immune component, contributes to inflammatory responses and graft damage during transplantation.
Purpose of the Study:
- To explore the role of the complement system in kidney transplantation.
- To discuss emerging complement inhibitory therapies for improving transplant outcomes.
- To highlight the potential of these therapies in mitigating ischemia/reperfusion injury and antibody-mediated rejection.
Main Methods:
- Review of existing literature on complement activation in transplantation.
- Analysis of the impact of complement on cellular and humoral immune responses to allografts.
- Discussion of novel complement inhibitory drugs and their mechanisms of action.
Main Results:
- The complement system critically influences inflammatory reactions, including ischemia/reperfusion injury.
- Complement activation modulates T and B cell responses to alloantigens, contributing to graft damage.
- Emerging complement inhibitors offer potential therapeutic avenues.
Conclusions:
- Targeting the complement cascade presents a promising strategy to enhance kidney transplant success.
- Complement inhibition can ameliorate ischemia/reperfusion injury and modulate adaptive immune responses.
- Novel therapies may prove effective in treating antibody-mediated rejection and improving long-term graft survival.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Complement System
Cell-mediated Immune Responses
Acute Kidney Injury II: Pathophysiology

